Bedaquiline versus placebo for management of multiple drug-resistant tuberculosis: A systematic review

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is associated with significant morbidity and mortality. Bedaquiline is the first drug approved for treating MDR-TB. OBJECTIVES: We performed a systematic review and meta-analysis to summarize the totality of all available evidence on the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Charan, Jaykaran, Reljic, Tea, Kumar, Ambuj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825437/
https://www.ncbi.nlm.nih.gov/pubmed/27127322
http://dx.doi.org/10.4103/0253-7613.178839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825437/
https://www.ncbi.nlm.nih.gov/pubmed/27127322
http://dx.doi.org/10.4103/0253-7613.178839

Ejemplares similares